The DOI matches its Crossref record.
Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone
Abstract
BACKGROUND: The aim was to assess possible treatment-induced gonadal damage in a cohort of adult female childhood cancer survivors (CCS) using anti-Müllerian hormone (AMH), the most sensitive marker of ovarian reserve. METHODS: A total cohort of 185 survivors was compared with 42 control subjects. The median follow-up time was 18.1 years (range 4.1-43.2 year). RESULTS: Median AMH concentrations in the analysed cohort were not different from controls (median 1.7 versus 2.1 microg/l; P = 0.57). However, AMH levels were lower than the 10th percentile of normal values in 27% (49/182) of our survivors. In addition, 43% (79/182) had AMH levels lower than 1.4 microg/l, a previously established cut-off value which predicts ongoing pregnancy after assisted reproduction. There were no differences in AMH levels in subgroups classified according to disease. However, survivors treated with three or more procarbazine containing chemotherapy cycles had significantly lower AMH levels than controls (median 0.5 microg/l; P = 0.004). Also survivors treated with abdominal or total body irradiation had significantly lower AMH levels than controls (median < 0.1 microg/l; P < 0.001). CONCLUSIONS: AMH can be used to identify subgroups of CCS at risk for decreased fertility or premature ovarian failure. In these survivors, options for fertility preservation should be considered prior to starting treatment since they may be at risk for poor chances of pregnancy after assisted reproductive treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The physiology and clinical utility of anti-Müllerian hormone in women
Dewailly, D., Andersen, C. Y., Balen, A., Broekmans, F., Dilaver, N., Fanchin, R., Griesinger, G., Kelsey, T. W., La Marca, A., Lambalk, C., et al. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt062 · Cited by 1,049
Self-citationChemotherapy-Induced Damage to Ovary: Mechanisms and Clinical Impact
Bedoschi, G., Navarro, P. A., & Oktay, K. (2016) · Future Oncology · doi:10.2217/fon-2016-0176 · Cited by 356
Barton, S. E., Najita, J. S., Ginsburg, E. S., Leisenring, W. M., Stovall, M., Weathers, R. E., Sklar, C. A., Robison, L. L., & Diller, L. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70251-1 · Cited by 337
Smitz, J., Dolmans, M. M., Donnez, J., Fortune, J. E., Hovatta, O., Jewgenow, K., Picton, H. M., Plancha, C., Shea, L. D., Stouffer, R. L., et al. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp056 · Cited by 306
Anderson, R. A., Mitchell, R. T., Kelsey, T. W., Spears, N., Telfer, E. E., & Wallace, W. H. B. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00039-x · Cited by 293
Metadata
- Authors
- Lie Fong, S., Laven, J. S. E., Hakvoort-Cammel, F. G. A. J., Schipper, I., Visser, J. A., Themmen, A. P. N., de Jong, F. H., & van den Heuvel-Eibrink, M. M.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-12-26
- Volume
- 24
- Issue
- 4
- Pages
- 982-990
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2107518748
- Cited by
- 190
- References
- 0
- FWCI
- 10.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone. https://app.cochat.ai/papers/10.1093/humrep/den487
- The paper
- Lie Fong, S., Laven, J. S. E., Hakvoort-Cammel, F. G. A. J., Schipper, I., Visser, J. A., Themmen, A. P. N., de Jong, F. H., & van den Heuvel-Eibrink, M. M. (2008). Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone. Human Reproduction. https://doi.org/10.1093/humrep/den487
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.